Uncategorized
BioTime Announces Name Change to Lineage Cell Therapeutics
ALAMEDA, Calif.--(BUSINESS WIRE)--<a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank">$BTX</a> <a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank">#AMD</a>--BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced it is launching a new corporate brand, including a change of its corporate name to Lineage Cell Therapeutics, Inc., effective August 12, 2019. In connection with the launch, the Company's NYSE American ticker symbol will change to "LCTX" and will be effective at the open of the market on August 12, 2019. Th